Lithium potentiation of neuroleptic-related extrapyramidal side effects.
D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D001714:Bipolar Disorder / Q000188:drug therapy; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008094:Lithium / Q000009:adverse effects*; D016651:Lithium Carbonate; D013997:Time Factors
D016651:Lithium Carbonate; D008094:Lithium; C011825:fluphenazine depot; D005476:Fluphenazine